Yu-Waye Chu, Senior VP Clinical Development at FATE THERAPEUTICS INC (FATE), sold 13,495 shares at $51.08 ($693K) on 2021-12-10, disclosed to the SEC on 2021-12-13.
Open-market sale of $693k FATE by Senior VP Clinical Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $49.32 | 2,097 | $103K | 14.9% |
| 2 | $49.32 | 2,097 | $103K | 14.9% |
| 3 | $50.42 | 900 | $45K | 6.5% |
| 4 | $51.08 | 1,045 | $53K | 7.7% |
| 5 | $51.08 | 1,045 | $53K | 7.7% |
| 6 | $52.37 | 1,822 |
| $95K |
| 13.8% |
| 7 | $52.37 | 1,822 | $95K | 13.8% |
| 8 | $53.66 | 1,031 | $55K | 8.0% |
| 9 | $53.66 | 1,031 | $55K | 8.0% |
| 10 | $54.58 | 600 | $33K | 4.7% |
| 11 | $55.54 | 5 | $278 | 0.0% |
| Total | $51.39 avg | 13,495 | $693K | 100% |
| Filing → |
| FATE | SELL | 2023-04-19 | $17K | — | Filing → |
| FATE | SELL | 2023-01-11 | $41K | — | Filing → |
| FATE | SELL | 2022-04-21 | $287K | — | Filing → |